Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Anru Wang in
Google Scholar
PubMed
Search for other papers by Xueqin Yan in
Google Scholar
PubMed
Search for other papers by Cai Zhang in
Google Scholar
PubMed
Search for other papers by Caiqi Du in
Google Scholar
PubMed
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Di Zhan in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
strongly correlated with changes in traits of the metabolic syndrome (FG, HOMA-IR and LDL-C), not with changes in BMI. Serum FGF1 was related to the degree of insulin resistance rather than to obesity (measured by BMI) per se . Weight loss as reported in
Search for other papers by Yali Cheng in
Google Scholar
PubMed
Search for other papers by Qiaoying Lv in
Google Scholar
PubMed
Search for other papers by Bingying Xie in
Google Scholar
PubMed
Search for other papers by Bingyi Yang in
Google Scholar
PubMed
Search for other papers by Weiwei Shan in
Google Scholar
PubMed
Search for other papers by Chengcheng Ning in
Google Scholar
PubMed
Search for other papers by Bing Li in
Google Scholar
PubMed
Search for other papers by Liying Xie in
Google Scholar
PubMed
Search for other papers by Chao Gu in
Google Scholar
PubMed
Search for other papers by Xuezhen Luo in
Google Scholar
PubMed
Search for other papers by Xiaojun Chen in
Google Scholar
PubMed
Search for other papers by Qin Zhu in
Google Scholar
PubMed
( 17 ), type 2 diabetes mellitus ( 18 ) and polycystic ovary syndrome (PCOS) ( 10 ), is the risk factor for EC. A prospective cohort study notes that ‘insulin resistance/metabolic syndrome,’ ‘steroids,’ and ‘inflammation’ factors are the three risk
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Signe Frøssing in
Google Scholar
PubMed
Department of Obstetrics & Gynecology, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Malin Nylander in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Department of Obstetrics & Gynecology, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Sven O Skouby in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
controls in cross-sectional studies, with contradicting results ( 13 , 14 , 15 , 16 , 17 , 18 ). Weight loss and improved insulin sensitivity are cornerstones in the treatment of the metabolic syndrome, T2D and PCOS. Glucagon-like peptide 1 receptor
Search for other papers by Yansu Wang in
Google Scholar
PubMed
Search for other papers by Yun Shen in
Google Scholar
PubMed
Search for other papers by Tingting Hu in
Google Scholar
PubMed
Search for other papers by Yufei Wang in
Google Scholar
PubMed
Search for other papers by Xiaojing Ma in
Google Scholar
PubMed
Search for other papers by Haoyong Yu in
Google Scholar
PubMed
Search for other papers by Yuqian Bao in
Google Scholar
PubMed
associations between serum clusterin levels and obesity, type 2 diabetes, dyslipidemia, metabolic syndrome, and premature coronary artery disease ( 13 , 14 , 15 , 16 ). One study has suggested that clusterin was a novel adipokine that linked cardiometabolic
Search for other papers by Amar Osmancevic in
Google Scholar
PubMed
Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed
Search for other papers by Margareta Hellgren in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
Search for other papers by Bledar Daka in
Google Scholar
PubMed
risk of having high CRP independent of total body weight, age, medication, or other comorbidities ( 23 ). In a cross-sectional study on Finnish non-diabetic men (1896 participants), results suggested metabolic syndrome as a great contributor to the high
Endocrinology Department, Hospital Militar Central, Bogotá, Colombia
Search for other papers by Mauricio Alvarez in
Google Scholar
PubMed
Search for other papers by Oswaldo Rincón Sierra in
Google Scholar
PubMed
Search for other papers by Ginna Saavedra in
Google Scholar
PubMed
Search for other papers by Sergio Moreno in
Google Scholar
PubMed
.04.001 ) 29709457 26 Khawaja N Abu-Shennar J Saleh M Dahbour SS Khader YS Ajlouni KM . The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan . Diabetology & Metabolic Syndrome 2018
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Julie Refardt in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Clara Odilia Sailer in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Bettina Winzeler in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Matthias Johannes Betz in
Google Scholar
PubMed
Search for other papers by Irina Chifu in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Ingeborg Schnyder in
Google Scholar
PubMed
Central Laboratory, University Hospital Würzburg, Würzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Leipzig University Medical Center, IFB Adiposity Diseases, Leipzig, Germany
Search for other papers by Wiebke Fenske in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Search for other papers by for the CODDI-Investigators in
Google Scholar
PubMed
obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis . Journal of Clinical Endocrinology and Metabolism 2012 97 2143 – 2150 . (doi:10.1210/jc.2012-1221) 10 Nakanishi K Nishida M Harada M Ohama T Kawada N
Search for other papers by Clarissa Souza Barthem in
Google Scholar
PubMed
Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Camila Lüdke Rossetti in
Google Scholar
PubMed
Search for other papers by Denise P Carvalho in
Google Scholar
PubMed
Search for other papers by Wagner Seixas da-Silva in
Google Scholar
PubMed
Introduction Metabolic syndrome is defined as the presence of at least three of a set of features, such as abdominal obesity, high fasting glycemia, high blood pressure and dyslipidemia, which is characterized by one or more disorders as
Search for other papers by Jay Toulany in
Google Scholar
PubMed
Search for other papers by Sebastian D Parlee in
Google Scholar
PubMed
Search for other papers by Christopher J Sinal in
Google Scholar
PubMed
Search for other papers by Kathryn Slayter in
Google Scholar
PubMed
Search for other papers by Shelly McNeil in
Google Scholar
PubMed
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
Search for other papers by Kerry B Goralski in
Google Scholar
PubMed
implicated chemerin as a target of interest in the pathophysiology of obesity and the metabolic syndrome. In line with a reputed role for chemerin in obesity, total chemerin concentrations are elevated in murine and human obesity, are correlated to markers of
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
Search for other papers by Martin Krššák in
Google Scholar
PubMed
Search for other papers by Michael Krebs in
Google Scholar
PubMed
, increased epicardial and pericardial fat is linked with changes in heart function in men suffering from metabolic syndrome ( 28 ), as well as in obese patients suffering from insulin resistance ( 29 ). Of note, MYCL and pericardial fat are two lipid stores